Debt-to-equity in % of ALX ONCOLOGY HOLDINGS INC from Q1 2021 to Q3 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
ALX ONCOLOGY HOLDINGS INC quarterly Debt-to-equity history and change rate from Q1 2021 to Q3 2025.
  • ALX ONCOLOGY HOLDINGS INC Debt-to-equity for the quarter ending 30 Sep 2025 was 44%, a 38% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

ALX ONCOLOGY HOLDINGS INC Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 44% +12% +38% 30 Sep 2025
Q2 2025 36% +6% +19% 30 Jun 2025
Q1 2025 34% +9% +36% 31 Mar 2025
Q4 2024 33% +11% +51% 31 Dec 2024
Q3 2024 32% +13% +69% 30 Sep 2024
Q2 2024 30% +16% +111% 30 Jun 2024
Q1 2024 25% +13% +98% 31 Mar 2024
Q4 2023 22% +11% +112% 31 Dec 2023
Q3 2023 19% +11% +151% 30 Sep 2023
Q2 2023 14% +9% +149% 30 Jun 2023
Q1 2023 13% +8% +181% 31 Mar 2023
Q4 2022 10% +6% +157% 31 Dec 2022
Q3 2022 7% +4% +137% 30 Sep 2022
Q2 2022 6% +3% +84% 30 Jun 2022
Q1 2022 5% 0% +6.1% 31 Mar 2022
Q4 2021 4% 31 Dec 2021
Q3 2021 3% 30 Sep 2021
Q2 2021 3% 30 Jun 2021
Q1 2021 4% 31 Mar 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.